It afforded us a far greater level of stakeholder engagement and buy-in than we would typically achieve for a one-off design (see below).
The potential of design to transform lives within the prison system and way beyond, is inspiring..If you'd like to continue to learn about our Design to Value approach and Modern Methods of Construction, sign up for our monthly newsletter here:.
http://bit.ly/BWNewsUpdatesDeveloping our Design to Value approach as pharmaceutical plant design consultants.In 2012, Bryden Wood and GlaxoSmithKline started working together to try and come up with a different approach to pharmaceutical capital projects.We started from the premise that while a great deal of effort was expended by a lot of expert people within both pharmaceutical and engineering companies, and despite the significant sums being spent, capital projects often failed to meet business requirements.
And how could we do better in our approach to pharmaceutical facility design?.We developed a particular set of tools and an approach that over time became what we now refer to as Design to Value.
As we have evolved this approach over the years, we’ve extended it to include many more pharmaceutical engineering projects, as well as a wide range of other sectors, from heavy industry to prisons.. Part of our role is to act as pharmaceutical plant design consultants.
What we aim to do is make sure that projects are well aligned with business requirements; to define and design future assets that translate a company’s strategic objectives into tangible manufacturing facilities – and provide added value.We know from the.
Lord Farmer Review into Family Ties.that connections with family and friends are key to rehabilitation.
The new design will have internal and external spaces in which prisoners and their visitors can socialise..The overall design allows for flexible use of spaces, meaning that facilities don’t go unused.